Range | Benign | Borderline | Stage I | Stage II-IV | Sec. meta |
---|---|---|---|---|---|
 | Models with CA125 | ||||
≥ 0.05, n (%) | 3043 (95) | 1762 (55) | 1324 (41) | 1347 (42) | 919 (29) |
≥ 0.10, n (%) | 1467 (46) | 537 (17) | 569 (18) | 1033 (32) | 467 (15) |
≥ 0.20, n (%) | 927 (29) | 245 (8) | 116 (4) | 665 (21) | 87 (3) |
≥ 0.30, n (%) | 514 (16) | 95 (3) | 14 (0.4) | 430 (13) | 4 (0.1) |
 | Models without CA125 | ||||
≥ 0.05, n (%) | 3100 (97) | 1889 (59) | 1221 (38) | 1655 (52) | 924 (29) |
≥ 0.10, n (%) | 1673 (52) | 532 (17) | 550 (17) | 1301 (41) | 388 (12) |
≥ 0.20, n (%) | 990 (31) | 260 (8) | 106 (3) | 697 (22) | 12 (0.4) |
≥ 0.30, n (%) | 523 (16) | 121 (4) | 13 (0.4) | 229 (7) | 0 |